Stéphanie Beq has 20 years of research and drug discovery & development experience in immunology. Prior to joining HiFiBiO Therapeutics as the Senior Director of Translational Science, she was head of the immunological laboratory at Cytheris SA, a privately held clinical‐stage biopharmaceutical company focused on research and development of new therapies for immune modulation. She also served as director of the immunological platform of the analytical department at Stallergenes, ensuring the development and quality of the platform through multiple biological products at different stages of development and simultaneously overseeing operational and project management activities. In 2015, Dr. Beq joined Alexion Pharmaceuticals, Inc. where she established a cell biology unit in Paris, France, recruited and managed scientific staff, developed core resources and cutting-edge technologies, and established academic collaborations.
Dr. Beq received her undergraduate and master’s degree from Université Paris VI, and a PhD in Immunology/Virology at Université Paris VII. She performed her postdoc reserach at the Pasteur Institute (Paris) under Nobel Laureate Dr. Françoise Barre‐Sinoussi.